A detailed history of First Light Asset Management, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, First Light Asset Management, LLC holds 3,076,555 shares of NEO stock, worth $50.4 Million. This represents 3.95% of its overall portfolio holdings.

Number of Shares
3,076,555
Previous 3,782,561 18.66%
Holding current value
$50.4 Million
Previous $52.5 Million 13.5%
% of portfolio
3.95%
Previous 4.78%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.4 - $17.73 $9.46 Million - $12.5 Million
-706,006 Reduced 18.66%
3,076,555 $45.4 Million
Q2 2024

Aug 14, 2024

BUY
$13.01 - $15.77 $6.25 Million - $7.58 Million
480,396 Added 14.55%
3,782,561 $52.5 Million
Q1 2024

May 15, 2024

SELL
$14.06 - $16.79 $8.78 Million - $10.5 Million
-624,591 Reduced 15.91%
3,302,165 $51.9 Million
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $14.4 Million - $25.6 Million
1,234,699 Added 45.86%
3,926,756 $63.5 Million
Q2 2023

Aug 14, 2023

SELL
$14.1 - $19.83 $97,304 - $136,846
-6,901 Reduced 0.26%
2,692,057 $43.3 Million
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $152,593 - $326,507
16,787 Added 0.63%
2,698,958 $47 Million
Q4 2022

Feb 14, 2023

SELL
$6.45 - $12.07 $244,635 - $457,790
-37,928 Reduced 1.39%
2,682,171 $24.8 Million
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $36,250 - $59,540
4,612 Added 0.17%
2,720,099 $23.4 Million
Q2 2022

Aug 12, 2022

BUY
$7.06 - $13.97 $13.5 Million - $26.7 Million
1,909,529 Added 236.93%
2,715,487 $22.1 Million
Q1 2022

May 13, 2022

BUY
$12.15 - $35.28 $510,919 - $1.48 Million
42,051 Added 5.5%
805,958 $9.79 Million
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $8.9 Million - $14.2 Million
-292,053 Reduced 27.66%
763,907 $26.1 Million
Q3 2021

Nov 12, 2021

SELL
$41.66 - $52.52 $3.87 Million - $4.88 Million
-92,985 Reduced 8.09%
1,055,960 $50.9 Million
Q2 2021

Aug 13, 2021

BUY
$36.62 - $51.69 $5.34 Million - $7.53 Million
145,729 Added 14.53%
1,148,945 $51.9 Million
Q1 2021

May 17, 2021

BUY
$41.56 - $59.88 $20.2 Million - $29.1 Million
486,125 Added 94.01%
1,003,216 $48.4 Million
Q4 2020

Feb 16, 2021

SELL
$36.08 - $56.47 $3.46 Million - $5.42 Million
-96,011 Reduced 15.66%
517,091 $27.8 Million
Q3 2020

Nov 13, 2020

BUY
$33.26 - $40.48 $13,969 - $17,001
420 Added 0.07%
613,102 $22.6 Million
Q2 2020

Aug 14, 2020

BUY
$24.21 - $31.02 $48,855 - $62,598
2,018 Added 0.33%
612,682 $19 Million
Q1 2020

May 15, 2020

SELL
$20.5 - $34.53 $14.9 Million - $25.1 Million
-726,285 Reduced 54.32%
610,664 $16.9 Million
Q4 2019

Feb 14, 2020

BUY
$18.96 - $29.84 $326,168 - $513,337
17,203 Added 1.3%
1,336,949 $39.1 Million
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $111,584 - $153,136
-5,836 Reduced 0.44%
1,319,746 $25.2 Million
Q2 2019

Aug 14, 2019

SELL
$19.57 - $24.1 $5.46 Million - $6.72 Million
-279,029 Reduced 17.39%
1,325,582 $29.1 Million
Q1 2019

May 15, 2019

SELL
$12.14 - $20.46 $7.33 Million - $12.3 Million
-603,577 Reduced 27.33%
1,604,611 $32.8 Million
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $16.8 Million - $27.6 Million
-1,492,739 Reduced 40.33%
2,208,188 $27.8 Million
Q3 2018

Nov 14, 2018

SELL
$12.5 - $15.38 $18.3 Million - $22.5 Million
-1,461,136 Reduced 28.31%
3,700,927 $56.8 Million
Q2 2018

Aug 14, 2018

BUY
$7.99 - $14.05 $3.21 Million - $5.64 Million
401,731 Added 8.44%
5,162,063 $67.7 Million
Q1 2018

May 15, 2018

BUY
$7.23 - $8.76 $6.6 Million - $8 Million
912,730 Added 23.72%
4,760,332 $38.8 Million
Q4 2017

Feb 14, 2018

BUY
$8.02 - $11.18 $11.5 Million - $16.1 Million
1,439,672 Added 59.79%
3,847,602 $34.1 Million
Q3 2017

Nov 14, 2017

SELL
$9.11 - $11.26 $2.47 Million - $3.06 Million
-271,341 Reduced 10.13%
2,407,930 $26.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,679,271
2,679,271 $24 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.